HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody IMMU-106

humanized anti-CD20 monoclonal antibody; used in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma
Also Known As:
IMMU-106; veltuzumab
Networked: 17 relevant articles (2 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goldenberg, David M: 15 articles (06/2015 - 04/2004)
2. Wegener, William A: 7 articles (06/2015 - 07/2009)
3. Rossi, Edmund A: 6 articles (04/2012 - 10/2008)
4. Chang, Chien-Hsing: 6 articles (04/2012 - 10/2008)
5. Cardillo, Thomas M: 4 articles (04/2012 - 10/2008)
6. Stein, Rhona: 4 articles (10/2009 - 04/2004)
7. Sharkey, Robert M: 3 articles (11/2014 - 10/2008)
8. Horne, Heather: 3 articles (09/2013 - 07/2009)
9. Byrd, John C: 2 articles (06/2015 - 04/2012)
10. Gupta, Pankaj: 2 articles (04/2012 - 10/2010)

Related Diseases

1. Lymphoma (Lymphomas)
2. Non-Hodgkin Lymphoma (Lymphosarcoma)
3. Neoplasms (Cancer)
4. B-Cell Lymphoma (Lymphoma, B Cell)
5. Thrombocytopenia (Thrombopenia)

Related Drugs and Biologics

1. rituximab (Mabthera)
2. milatuzumab
3. hLL2 agent (epratuzumab)
4. Immunoglobulin G (IgG)
5. Antibodies
6. Complement System Proteins (Complement)
7. Inosine Triphosphate (ITP)
8. Immunoglobulins (Immunoglobulin)
9. Steroids
10. Antigens

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Stem Cell Transplantation
3. Subcutaneous Injections